US2021113612A1PendingUtilityA1
Blood Plasma and Plasma Fractions as Therapy for Tumor Growth and Progression
Est. expiryApr 28, 2036(~9.8 yrs left)· nominal 20-yr term from priority
A61K 35/16A61P 35/00
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to treating individuals with cancer by using blood plasma or blood plasma fractions as treatment.
Claims
exact text as granted — not AI-modifiedWhat is claimed:
1 . A method of treating a cancer, the method comprising administering an effective amount of a blood plasma product to a subject diagnosed with the cancer.
2 . The method of claim 1 , wherein the blood plasma product is a young plasma.
3 . The method of claim 1 , wherein the blood plasma product is a Plasma Fraction.
4 . The method of claim 3 , wherein the Plasma Fraction is a Plasma Protein Fraction.
5 . The method of claim 4 , wherein the Plasma Protein Fraction is a commercially available Plasma Protein Fraction.
6 . The method of claim 3 , wherein the Plasma Fraction is a protein-enriched plasma protein product.
7 . The method of claim 1 , wherein the cancer is comprised of a solid tumor.
8 . The method of claim 1 , wherein the cancer is a hematopoietic cancer.
9 . The method of claim 1 , wherein the cancer is a colorectal cancer.
10 . The method of claim 1 , wherein the cancer is a gastric cancer.
11 . The method of claim 1 , wherein the cancer is a liver cancer.
12 . The method of claim 1 , wherein the cancer is a B lymphocyte Burkitt's lymphoma.
13 . The method of claim 1 , wherein the cancer is a renal cancer.
14 . The method of claim 1 , wherein the cancer is a thymic cancer.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.